Retatrutide and the Future of Obesity Treatment: Insights from the TRIUMPH-1 Study The landscape of obesity medicine is evolving rapidly. Eli Lilly’s investigational drug, retatrutide, has recently garnered significant attention …
Tag:
Zepbound
-
-
Understanding the Recent Performance and Development Landscape of Eli Lilly In the rapidly evolving landscape of pharmaceutical development, Eli Lilly remains a central figure, particularly as investors and patients alike …
-
Oral Wegovy Approved: A New Option for Weight Loss A new oral version of the weight loss drug Wegovy has been approved by the Food and Drug Administration (FDA), offering …
-
Trump’s “Liberation Day” Tariffs: A Year of Unexpected Economic Resilience When Donald Trump famously announced his “Liberation Day” tariff assault on the world in April 2025, economists widely predicted a …